SHOW

Blis Technologies researches, manufactures and sells probiotics intended for the human oral cavity. Our company has developed two strains of the commensal oral bacteria Streptococcus salivarius, characterising their unique anti-bacterial properties to support functional benefits. Commercialisation has presented many challenges but also the opportunity to develop evidence based products for ear nose and throat health. This talk will highlight our journey and present both successes and challenges as we develop proof of concept products.